Eckert & Ziegler SE (EKZRF)
15.57
0.00 (0.00%)
USD |
OTCM |
Oct 08, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | -- |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | -- |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | -- |
| Price to Book Value | -- |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | 0.2561 |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | -- |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | -- |
Profile
| Eckert & Ziegler SE is a holding company, which engages in the processing of radio isotopes. It also focuses on the development, production, and sale of isotope technology components and related products. It operates through the following segments: Isotope Products, Medical, and Other. The Isotope Products segment manufactures and distributes standards, and radiation sources for medical and industrial purposes. The Medical segment offers small radioactive implants for treating prostate cancer and eye applications for treating uveal melanoma. The Other segment focuses pools internal group services like radiation protection, legal, accounting, information technology, and human resources. The company was founded by Andreas Eckert in 1997 and is headquartered in Berlin, Germany. |
| URL | http://www.ezag.com |
| Investor Relations URL | N/A |
| HQ State/Province | Berlin |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Equity Style | N/A |
| Next Earnings Release | Nov. 12, 2026 |
| Last Earnings Release | Aug. 13, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Jun. 26, 2026 |
Profile
| Eckert & Ziegler SE is a holding company, which engages in the processing of radio isotopes. It also focuses on the development, production, and sale of isotope technology components and related products. It operates through the following segments: Isotope Products, Medical, and Other. The Isotope Products segment manufactures and distributes standards, and radiation sources for medical and industrial purposes. The Medical segment offers small radioactive implants for treating prostate cancer and eye applications for treating uveal melanoma. The Other segment focuses pools internal group services like radiation protection, legal, accounting, information technology, and human resources. The company was founded by Andreas Eckert in 1997 and is headquartered in Berlin, Germany. |
| URL | http://www.ezag.com |
| Investor Relations URL | N/A |
| HQ State/Province | Berlin |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Equity Style | N/A |
| Next Earnings Release | Nov. 12, 2026 |
| Last Earnings Release | Aug. 13, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Jun. 26, 2026 |